iotaMotion Surpasses 1,000 Clinical Procedures Performed with iotaSOFT® --Defining a New Era in Cochlear Implant Surgery

 iotaMotion, Inc., the leader in robotic-assisted insertion systems for cochlear implantation, today announced it surpassed 1,000 clinical procedures utilizing the iotaSOFT^® Insertion System. This milestone underscores growing adoption of the first and only FDA market authorized robotic-assisted cochlear implant insertion system in the United States. The system provides surgeons with enhanced precision, consistency and control to one of the most delicate steps in cochlear implant (CI) surgery.

Now in its second full year of commercialization, iotaSOFT has been adopted in more than 30 leading cochlear implant centers nationwide, as well as an active pre-market clinical study site in Zurich, Switzerland.

"Cochlear implantation is one of the most transformative surgeries in medicine, yet for decades this critical step, electrode array insertion, has relied solely on the limits of the human hand," said Mike Lobinsky, CEO of iotaMotion. "With iotaSOFT, we are advancing CI surgery beyond human capability. By standardizing insertion and expanding access to the latest technology, we are not only empowering surgeons but also breaking down patient barriers like fear of surgery, opening the door for millions who could benefit."

Read more here